For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Ivermectin Group | Contacts who will receive prophylactic ivermectin Ivermectin Tablets: 40-60 kg (15mg/day) 60-80kg (18mg/day) \>80kg (24mg/day) | 0 | None | 0 | 203 | 11 | 203 | View |
| Control Group | Contacts who will be only observed without prophylaxis | 0 | None | 0 | 101 | 0 | 101 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| nausea | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| diarrhea | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| burning sensation | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| tingling/numbness | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| heart burn | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| sleepiness | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| fatigue | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| abdominal pain | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |